Dr. Salil Goorha
Claim this profileBaptist Memorial Hospital and Cancer Center-Memphis
Area of expertise
Acute Myeloid Leukemia
Salil Goorha has run 3 trials for Acute Myeloid Leukemia. Some of their research focus areas include:
Acute Myelogenous Leukemia
Salil Goorha has run 3 trials for Acute Myelogenous Leukemia. Some of their research focus areas include:
Affiliated Hospitals
Baptist Memorial Hospital And Cancer Center-Memphis
Baptist Memorial Hospital And Cancer Center-Desoto
Clinical Trials Salil Goorha is currently running
Blinatumomab + Chemotherapy
for Leukemia
This phase III trial compares the effect of usual treatment of chemotherapy and steroids and a tyrosine kinase inhibitor (TKI) to the same treatment plus blinatumomab. Blinatumomab is a Bi-specific T-Cell Engager ('BiTE') that may interfere with the ability of cancer cells to grow and spread. The information gained from this study may help researchers determine if combination therapy with steroids, TKIs, and blinatumomab work better than the standard of care.
Recruiting
2 awards
Phase 3
10 criteria
Novel Therapies
for Acute Myeloid Leukemia
This phase II MyeloMATCH treatment trial tests whether the standard approach of cytarabine and daunorubicin in comparison to the following experimental regimens works to shrink cancer in patients with high risk acute myeloid leukemia (AML): 1) daunorubicin and cytarabine liposome alone; 2) cytarabine and daunorubicin with venetoclax; 3) azacitidine and venetoclax; 4) daunorubicin and cytarabine liposome and venetoclax. "High-risk" refers to traits that have been known to make the AML harder to treat. Cytarabine is in a class of medications called antimetabolites. It works by slowing or stopping the growth of cancer cells in the body. Daunorubicin is in a class of medications called anthracyclines. It also works by slowing or stopping the growth of cancer cells in the body. Azacitidine is in a class of medications called demethylation agents. It works by helping the bone marrow to produce normal blood cells and by killing abnormal cells. Venetoclax is in a class of medications called B-cell lymphoma-2 (BCL-2) inhibitors. It may stop the growth of cancer cells by blocking Bcl-2, a protein needed for cancer cell survival. There is evidence that these newer experimental treatment regimens may work better in getting rid of more AML compared to the standard approach of cytarabine and daunorubicin.
Recruiting
1 award
Phase 2
17 criteria
More about Salil Goorha
Clinical Trial Related
6 years of experience running clinical trials · Led 9 trials as a Principal Investigator · 6 Active Clinical Trials
Treatments Salil Goorha has experience with
- Cytarabine
- Venetoclax
- Azacitidine
- Daunorubicin Hydrochloride
- Doxorubicin Hydrochloride
- Biospecimen Collection
Breakdown of trials Salil Goorha has run
Acute Myeloid Leukemia
Acute Myelogenous Leukemia
Central Nervous System Hodgkin Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Salil Goorha specialize in?
Salil Goorha focuses on Acute Myeloid Leukemia and Acute Myelogenous Leukemia. In particular, much of their work with Acute Myeloid Leukemia has involved t(9;22) translocation positive patients, or patients who are FLT3 positive.
Is Salil Goorha currently recruiting for clinical trials?
Yes, Salil Goorha is currently recruiting for 6 clinical trials in Memphis Tennessee. If you're interested in participating, you should apply.
Are there any treatments that Salil Goorha has studied deeply?
Yes, Salil Goorha has studied treatments such as Cytarabine, Venetoclax, Azacitidine.
What is the best way to schedule an appointment with Salil Goorha?
Apply for one of the trials that Salil Goorha is conducting.
What is the office address of Salil Goorha?
The office of Salil Goorha is located at: Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee 38120 United States. This is the address for their practice at the Baptist Memorial Hospital and Cancer Center-Memphis.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.